Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations
Phase of Trial: Phase IV
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Influenza A virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors sanofi pasteur
- 28 Jun 2017 Status changed from active, no longer recruiting to completed.
- 29 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 29 Sep 2016 New trial record